heart disease

Dublin, Ireland & Bridgewater, N.J. – August 28, 2026 Amarin Corporation announced new post hoc findings from the landmark...

THE WOODLANDS, Texas, July 27, 2026 Lexicon Pharmaceuticals, Inc. announced the completion of patient enrollment and randomization in the...

TORONTO, Ontario, July 14, 2026 Cardiol Therapeutics Inc. has announced the publication of its Phase II MAvERIC clinical trial...

MELBOURNE, Australia, June 29, 2026 4DMedical has achieved a major regulatory milestone with the Therapeutic Goods Administration (TGA) approving...

SOMERSET, N.J., June 29, 2026 Terumo Interventional Systems (TIS), a division of Terumo Corporation, has announced the successful completion...

SANTA CLARA, Calif., June 17, 2026 VahatiCor, Inc., a medical device company focused on developing innovative therapies for coronary...

EVANSTON, Ill., June 2, 2026 Researchers at Endeavor Health have developed a groundbreaking genetic screening tool designed to provide...

MONTREAL, Canada, May 29, 2026 Leica Biosystems, a global leader in anatomic and digital pathology solutions, and CellCarta, a...

CHICAGO, Ill., May 29, 2026 Cardiosense has achieved a major regulatory milestone with the U.S. Food and Drug Administration...

ENCINITAS, Calif., May 11, 2026 Vasa Therapeutics, a clinical-stage biotechnology company focused on therapies targeting cardiovascular and metabolic aging,...